Christina DeRuzza
Associate Director
20+ years of experience
Christina joined Citeline in 2007, having worked as a scientist at Harvard Medical School studying the genetics and molecular biology of the developing cerebral cortex.
Christina DeRuzza 30 Mar 2016
The race for an approved non-interferon regimen to treat Hepatitis C Virus (HCV) infections in China is on and market stakes are high.